IDBS software to drive Quebec personalized cancer programme

PharmaTimes

February 2014

IDBS has been enlisted in a Canadian programme that aims to redefine cancer as a collection of rare diseases with specific molecular signatures, aiding stratification in drug development.

Read the article here »